Federal (United States) · Statute compilation
Title XI
31 sections
31 sections
- Pub. L. 112-144, tit. XI, subtit. A, sec. 1101 (as amended)REAUTHORIZATION OF PROVISION RELATING TO EXCLUSIVITY OF CERTAIN DRUGS CONTAINING SINGLE ENANTIOMERS.
- Pub. L. 112-144, tit. XI, subtit. A, sec. 1102 (as amended)REAUTHORIZATION OF THE CRITICAL PATH PUBLIC-PRIVATE PARTNERSHIPS.
- Pub. L. 112-144, tit. XI, subtit. B, sec. 1111 (as amended)REGULATION OF MEDICAL GASES.
- Pub. L. 112-144, tit. XI, subtit. B, sec. 1112 (as amended)CHANGES TO REGULATIONS.
- Pub. L. 112-144, tit. XI, subtit. B, sec. 1113 (as amended)RULES OF CONSTRUCTION.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1121 (as amended)GUIDANCE DOCUMENT REGARDING PRODUCT PROMOTION USING THE INTERNET.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1122 (as amended)COMBATING PRESCRIPTION DRUG ABUSE.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1123 (as amended)OPTIMIZING GLOBAL CLINICAL TRIALS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1124 (as amended)ADVANCING REGULATORY SCIENCE TO PROMOTE PUBLIC HEALTH INNOVATION.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1125 (as amended)INFORMATION TECHNOLOGY.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1126 (as amended)NANOTECHNOLOGY.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1127 (as amended)ONLINE PHARMACY REPORT TO CONGRESS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1128 (as amended)REPORT ON SMALL BUSINESSES.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1129 (as amended)PROTECTIONS FOR THE COMMISSIONED CORPS OF THE PUBLIC HEALTH SERVICE ACT.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1130 (as amended)COMPLIANCE DATE FOR RULE RELATING TO SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1131 (as amended)STRATEGIC INTEGRATED MANAGEMENT PLAN.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1132 (as amended)ASSESSMENT AND MODIFICATION OF REMS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1133 (as amended)EXTENSION OF PERIOD FOR FIRST APPLICANT TO OBTAIN TENTATIVE APPROVAL WITHOUT FORFEITING 180-DAY-EXCLUSIVITY PERIOD.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1134 (as amended)DEADLINE FOR DETERMINATION ON CERTAIN PETITIONS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1135 (as amended)FINAL AGENCY ACTION RELATING TO PETITIONS AND CIVIL ACTIONS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1136 (as amended)ELECTRONIC SUBMISSION OF APPLICATIONS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1137 (as amended)PATIENT PARTICIPATION IN MEDICAL PRODUCT DISCUSSIONS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1138 (as amended)ENSURING ADEQUATE INFORMATION REGARDING PHARMACEUTICALS FOR ALL POPULATIONS, PARTICULARLY UNDERREPRESENTED SUBPOPULATIONS, INCLUDING RACIAL SUBGROUPS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1139 (as amended)SCHEDULING OF HYDROCODONE.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1140 (as amended)STUDY ON DRUG LABELING BY ELECTRONIC MEANS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1141 (as amended)RECOMMENDATIONS ON INTEROPERABILITY STANDARDS.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1142 (as amended)CONFLICTS OF INTEREST.
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1143 (as amended)NOTIFICATION OF FDA INTENT TO REGULATE LABORATORY-DEVELOPED TESTS.
- Pub. L. 112-144, tit. XI, subtit. D, sec. 1151 (as amended)SHORT TITLE.
- Pub. L. 112-144, tit. XI, subtit. D, sec. 1152 (as amended)ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.
- Pub. L. 112-144, tit. XI, subtit. D, sec. 1153 (as amended)TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.